Arbutus Biopharma Corporation (ABUS)

USD 3.19

(-7.8%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 144.4 Million 195.41 Million 204.48 Million 137.08 Million 105.53 Million 227.9 Million
Total Current Assets 132.02 Million 151.13 Million 160.66 Million 127.7 Million 93.82 Million 129.2 Million
Cash And Short Term Investments 126 Million 146.91 Million 155.31 Million 123.26 Million 90.83 Million 124.6 Million
Cash and Cash Equivalents 26.28 Million 30.77 Million 109.28 Million 52.25 Million 31.79 Million 36.9 Million
Short Term Investments 99.71 Million 116.13 Million 46.03 Million 71.01 Million 59.03 Million 87.7 Million
Net Receivables 2.37 Million 4.22 Million 5.34 Million 4.43 Million 1.2 Million 1.4 Million
Inventory -1.77 Million -2.87 Million -4.44 Million -3.12 Million - -
Other Current Assets 3.64 Million 2.87 Million 4.44 Million 3.12 Million 1.79 Million 3.2 Million
Total Non-Current Assets 12.37 Million 44.28 Million 43.82 Million 9.37 Million 11.7 Million 98.7 Million
Net PPE 6.09 Million 6.81 Million 8.07 Million 9.33 Million 11.41 Million 10.2 Million
Good Will And Intangible Assets - - - - - 66.3 Million
Good Will - - - - - 22.5 Million
Intangible Assets - - - - - 43.8 Million
Long-Term Investments 6.28 Million 37.36 Million 35.68 Million - - 22.2 Million
Tax Assets - - - - - -22.22 Million
Other Non Current Assets - 103 Thousand 61 Thousand 44 Thousand 293 Thousand 22.22 Million
Other Assets 1.00 - - - - -
Total Liabilities 38.38 Million 58.56 Million 35.04 Million 35.11 Million 32.79 Million 27.7 Million
Total Current Liabilities 22.48 Million 32.85 Million 11.22 Million 9.54 Million 7.82 Million 10 Million
Account Payables 3.22 Million 3.52 Million 3.17 Million 2.99 Million 2.39 Million 3.19 Million
Tax Payables - - - - - -
Short Term Debt 425 Thousand 372 Thousand 383 Thousand 390 Thousand 340 Thousand -
Deferred Revenue 11.79 Million 16.45 Million 7.63 Million 5.9 Million 4.83 Million -
Other Current Liabilities 7.04 Million 12.5 Million 26 Thousand 250 Thousand 253 Thousand 6.8 Million
Total Non Current Liabilities 15.89 Million 25.71 Million 23.82 Million 25.57 Million 24.96 Million 17.7 Million
Long-Term Debt 6.95 Million 1.81 Million 2.23 Million 2.59 Million 3.01 Million -
Deferred Revenue Non Current - 5.99 Million - - 18.99 Million -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 8.94 Million 17.89 Million 21.59 Million 22.98 Million 21.94 Million 5 Million
Other Liabilities - - - - - -
Total Equity 106.01 Million 136.85 Million 169.43 Million 101.96 Million 72.74 Million 200.2 Million
Stock Holders Equity 106.01 Million 136.85 Million 169.43 Million 101.96 Million 72.74 Million 200.2 Million
Common Stock 1.34 Billion 1.31 Billion 1.28 Billion 985.93 Million 898.53 Million 879.4 Million
Retained Earnings -1.27 Billion -1.2 Billion -1.13 Billion -1.04 Billion -970.09 Million -805.22 Million
Accumulated other comprehensive income -48.42 Million -50.48 Million -48.33 Million -48.17 Million -48.22 Million -48.17 Million
Common Stock Equity 106.01 Million 136.85 Million 169.43 Million 101.96 Million 72.74 Million 200.2 Million
Capital Lease Obligation 1.34 Million 2.18 Million 2.61 Million 2.98 Million 3.35 Million -
Total Investments 106 Million 153.5 Million 81.72 Million 71.01 Million 59.03 Million 109.89 Million
Total Debt 8.72 Million 2.18 Million 2.61 Million 2.98 Million 3.35 Million -
Net Debt -17.56 Million -28.58 Million -106.66 Million -49.26 Million -28.44 Million -36.9 Million

Balance Sheet Charts